Internal restructuring
European Union
Location of affected unit(s)
Belgium, the Netherlands, France, Germany, Italy, Spain, Switzerland, UK
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

500 jobs
Number of planned job losses
Job loss
Announcement Date
18 April 2011
Employment effect (start)
18 April 2011
Foreseen end date
31 December 2012


The specialty pharmaceutical company Warner Chilcott announced on 18 April 2011 that it would restructure its western Europe operations and cut around a fifth of its workforce following the fact that its key osteoporosis drug (Actonel) lost exclusivity in 2010. The company has said that the restructuring will take place in Belgium, the Netherlands, France, Germany, Italy, Spain, Switzerland and the UK, but will not impact its operations at its headquarters in Dublin, Ireland. It expects the restructuring to be completed by the end of 2012.


  • 18 April 2011: Reuters


Eurofound (2011), Warner Chilcott, Internal restructuring in European Union, factsheet number 71887, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71887.